A more recent study confirmed this finding, showing that KIF3a is necessary for medulloblastoma initiation and maintenance and that conditional ablation of Kif3a levels during tumor formation in vivo is followed by tumor regression [14]. The gene discussed is KIF3A; the disease is neoplasm.